A detailed history of Farther Finance Advisors, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 56 shares of ATRC stock, worth $1,716. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56
Previous 25 124.0%
Holding current value
$1,716
Previous $563,000 178.86%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$20.34 - $29.5 $630 - $914
31 Added 124.0%
56 $1.57 Million
Q1 2024

May 13, 2024

SELL
$28.21 - $37.78 $2,228 - $2,984
-79 Reduced 75.96%
25 $727,000
Q4 2023

Feb 14, 2024

BUY
$32.99 - $43.25 $3,430 - $4,498
104 New
104 $3.71 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.42B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.